SG48764A1 - Pharmaceutical compositions and method using isobutyramide for treating betaglobib disorders - Google Patents

Pharmaceutical compositions and method using isobutyramide for treating betaglobib disorders

Info

Publication number
SG48764A1
SG48764A1 SG1996001424A SG1996001424A SG48764A1 SG 48764 A1 SG48764 A1 SG 48764A1 SG 1996001424 A SG1996001424 A SG 1996001424A SG 1996001424 A SG1996001424 A SG 1996001424A SG 48764 A1 SG48764 A1 SG 48764A1
Authority
SG
Singapore
Prior art keywords
isobutyramide
disorders
betaglobib
treating
pharmaceutical compositions
Prior art date
Application number
SG1996001424A
Other languages
English (en)
Inventor
Susan P Perrine
Original Assignee
Childrens Hosp Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp Medical Center filed Critical Childrens Hosp Medical Center
Publication of SG48764A1 publication Critical patent/SG48764A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1996001424A 1992-03-17 1993-03-17 Pharmaceutical compositions and method using isobutyramide for treating betaglobib disorders SG48764A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/852,511 US5439939A (en) 1992-03-17 1992-03-17 Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders

Publications (1)

Publication Number Publication Date
SG48764A1 true SG48764A1 (en) 1998-05-18

Family

ID=25313524

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996001424A SG48764A1 (en) 1992-03-17 1993-03-17 Pharmaceutical compositions and method using isobutyramide for treating betaglobib disorders

Country Status (10)

Country Link
US (1) US5439939A (de)
EP (1) EP0697862B1 (de)
AT (1) ATE181235T1 (de)
AU (1) AU3810693A (de)
DE (1) DE69325393T2 (de)
DK (1) DK0697862T3 (de)
ES (1) ES2135470T3 (de)
GR (1) GR3031241T3 (de)
SG (1) SG48764A1 (de)
WO (1) WO1993018761A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
IT1273628B (it) * 1993-06-04 1997-07-08 Emerging Pharmaceutical Techno Composizioni farmaceutiche per la cura della talassemia contenenti derivati dell'acido butirrico e in particolare isobutirramide
US5569675A (en) * 1994-03-07 1996-10-29 Bar Ilan University Methods of using carboxylic acid esters to increase fetal-hemoglobin levels
US5700640A (en) * 1994-09-16 1997-12-23 Basf Aktiengesellschaft Inducers of gamma globin gene expression and screening assays therefor
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
US6822267B1 (en) * 1997-08-20 2004-11-23 Advantest Corporation Signal transmission circuit, CMOS semiconductor device, and circuit board
AU774861B2 (en) 1998-02-11 2004-07-08 Douglas V Faller Compositions and methods for the treatment of cystic fibrosis
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
FR2847817B1 (fr) * 2002-11-28 2006-11-10 Centre Nat Rech Scient Utilisation d'un inhibiteur d'histone deacetylase pour le traitement des dystrophies musculaires
US7381825B2 (en) 2003-03-17 2008-06-03 Takeda San Diego, Inc. Histone deacetylase inhibitors
US20070042937A1 (en) * 2003-08-01 2007-02-22 Fibrogen, Inc. Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers
JP2008524246A (ja) 2004-12-16 2008-07-10 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
JP2008540574A (ja) 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
BRPI0613429A2 (pt) 2005-07-14 2009-02-10 Takeda San Diego Inc inibidores de histona desacetilase
US20070185045A1 (en) * 2006-02-06 2007-08-09 Ratcliffe Peter J Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
EP2509418A4 (de) 2009-12-08 2013-03-20 Hemaquest Pharmaceuticals Inc Verfahren und niedrigdosierungspläne zur behandlung von erythrozytendysfunktion
WO2011113013A2 (en) 2010-03-11 2011-09-15 Hemaquest Pharmaceuticals, Inc. Methods and compositions for treating viral or virally-induced conditions
WO2013119800A1 (en) 2012-02-07 2013-08-15 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
US9724396B2 (en) 2013-03-15 2017-08-08 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
WO2016064815A1 (en) * 2014-10-20 2016-04-28 Massachusetts Institute Of Technology Functional ghrelin receptor antagonism during pregnancy to prevent stress-associated mental illness in offspring and mothers
WO2016138099A1 (en) 2015-02-24 2016-09-01 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
KR20220034736A (ko) 2019-05-31 2022-03-18 비락타 서브시디어리 인크. 히스톤 데아세틸라제 억제제를 사용하여 바이러스 관련 암을 치료하는 방법
CA3236051A1 (en) 2021-10-19 2023-04-27 Akirabio, Inc. Compositions comprising 2'-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482571A (en) * 1982-06-21 1984-11-13 University Of Pittsburgh Sickle cell anemia treatment and compound
US5025029A (en) * 1986-10-10 1991-06-18 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin
US4822821A (en) * 1986-10-10 1989-04-18 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin
SG86966A1 (en) * 1988-11-29 2002-03-19 Childrens Hosp Medical Center Medicament for augmenting fetal hemoglobin

Also Published As

Publication number Publication date
DE69325393D1 (de) 1999-07-22
EP0697862B1 (de) 1999-06-16
GR3031241T3 (en) 1999-12-31
ATE181235T1 (de) 1999-07-15
WO1993018761A1 (en) 1993-09-30
DK0697862T3 (da) 1999-12-13
AU3810693A (en) 1993-10-21
US5439939A (en) 1995-08-08
ES2135470T3 (es) 1999-11-01
DE69325393T2 (de) 1999-12-16
EP0697862A4 (de) 1996-05-29
EP0697862A1 (de) 1996-02-28

Similar Documents

Publication Publication Date Title
SG48764A1 (en) Pharmaceutical compositions and method using isobutyramide for treating betaglobib disorders
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
UA48939C2 (uk) Дизаміщені фуранони, способи їх одержання, фармацевтична композиція на їх основі, спосіб лікування запального захворювання, проміжні сполуки
GR3030342T3 (en) Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase.
IL162214A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
TW217407B (de)
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
BG101209A (en) Hypolipidemic compounds
IL93556A0 (en) Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents
HK1027802A1 (en) Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
AP9701019A0 (en) Phenylamino-substituted tricycle derivatives.
UA48940C2 (uk) Рекомбінатні il4 антитіла, які використовуються для лікування il4-опосередкованих порушень
HUT63320A (en) Process for producing pharmaceutical composition for treating alopecia
IL111293A0 (en) Pharmaceutical compositions comprising 5 alpha-reductase type 2 inhibitor for treating androgenic alopecia
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
JPS6470417A (en) Method and composition for treating psoriasis
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
GR3020575T3 (en) New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions
UA48962C2 (uk) Біциклічні антагоністи тахікінінів, фармацевтична композиція та спосіб лікування
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
ATE155136T1 (de) Neue bishispidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE242766T1 (de) Neue derivate von benzoylalkyl-1,2,3,6- tetrahydropyridinen